SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-04
👔
LIGAND PHARMACEUTICALS INC
@LGND_InsiderForm 4 Filing: Reardon Andrew Sells $1.7M of $LGND
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
LIGAND PHARMACEUTICALS INC
Ticker: $LGND
Transaction Value
$1.7M
Price/Share: $170.63
transaction date
2026-08-03
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Reardon Andrew, holds the title of CLO & Secretary at LIGAND PHARMACEUTICALS INC.
On 2026-08-03, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $170.63 per share, resulting in a total market-relevant value of $1.7M.
Executive Summary Summary
Reardon Andrew (CLO & Secretary) sold $1.7M of $LGND
Post-Transaction Position: 43,973 shares
SEC Accession No: 0002001011-26-000111 (CIK: 1950232)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.